Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...
Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Delaying onboarding until FDA approval reduces sunk-cost risk but can impede institutional learning and slow post-approval ...
FibroBiologics is planning a prospective, multicenter, open-label clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to 12 ...
Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...
Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...
The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results